Ten years of clinical experience with spinal cord stimulation for chronic pain: a retrospective cohort study and review of evolving stimulation paradigms
Folia Medica · 08.06.2026 · 68 (3)
DOI: 10.3897/folmed.68.e177992 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Folia Medica, online erschienen am 08.06.2026. Verfasst von Dimitar Slavkov und 1 weiteren Autor:innen. Beteiligte Einrichtung: Helios Vogtlandklinik Plauen, Plauen, Germany. Hauptthemen laut MEDLINE: Spinal Cord Stimulation, Chronic Pain, Neuralgia. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Introduction
Spinal cord stimulation (SCS) is an established therapy for refractory chronic neuropathic pain unresponsive to conventional management. Recent developments, including burst, high-frequency, and closed-loop stimulation, have broadened therapeutic options, though long-term comparative data remain limited.
Aim
To assess the long-term efficacy, safety, and durability of various SCS modalities over a 10-year period in patients with chronic neuropathic pain. Materials and methods : A retrospective analysis of 312 patients who underwent SCS implantation (2015–2024) at a tertiary pain center. Outcomes included pain intensity (NRS), disability (ODI), quality of life (EQ-5D-5L), and opioid use, measured at baseline and up to 36 months. Statistical analyses compared stimulation modalities and identified predictors of sustained clinical success (≥50% pain reduction at 24 months).
Results
The cohort (mean age 57.2 years; 58.6% female) primarily included persistent spinal pain syndrome (46.5%), complex regional pain syndrome (28.8%), and diabetic polyneuropathy (15.4%). Modalities were tonic (31.1%), burst (21.8%), high-frequency (30.8%), and closed-loop (16.3%). Mean pain reduction at 12 months was 63.7% (NRS 8.1 → 2.9; p <0.001). High-frequency and closed-loop systems provided superior relief (≈70%) versus tonic stimulation (54%; p <0.01). ODI improved from 61.4 to 34.2, EQ-5D-5L from 0.32 to 0.71 ( p <0.001), and opioid use declined by 60%, with 42.5% discontinuation at 24 months. Complications occurred in 11.9%, and explantation in 8.0%, lowest for advanced systems. Predictors of sustained success included age <60 years, non-smoking status, and use of high-frequency/closed-loop systems.
Conclusion
SCS provides durable pain relief, functional improvement, and opioid reduction in chronic neuropathic pain. High-frequency and closed-loop modalities show superior long-term outcomes and should be considered preferred therapeutic options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Helios Vogtlandklinik Plauen, Plauen, Germany.
ORCID-Profile: Dimitar Slavkov, Svetoslava Troyanova-Slavkova
Zitieren
APA
Slavkov, D., & Troyanova-Slavkova, S. (2026). Ten years of clinical experience with spinal cord stimulation for chronic pain: a retrospective cohort study and review of evolving stimulation paradigms. Folia Medica, 68(3). https://doi.org/10.3897/folmed.68.e177992
Vancouver
Slavkov D, Troyanova-Slavkova S. Ten years of clinical experience with spinal cord stimulation for chronic pain: a retrospective cohort study and review of evolving stimulation paradigms. Folia Medica. 2026;68(3). doi:10.3897/folmed.68.e177992
BibTeX
@article{Slavkov2026,
author = {Slavkov, Dimitar and Troyanova-Slavkova, Svetoslava},
title = {Ten years of clinical experience with spinal cord stimulation for chronic pain: a retrospective cohort study and review of evolving stimulation paradigms},
journal = {Folia Medica},
year = {2026},
volume = {68},
number = {3},
doi = {10.3897/folmed.68.e177992}
}
EUVIMED